Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Aug. 31, 2024	Aug. 31, 2023
Cash Flows From Operating Activities:
Net income (loss) available to common shareholders	$ (1,377)	$ 49,654
Dividends on preferred stock	1,200	7,200
Plus: Redemption premium on Series A Preferred Stock	75,198	0
Net income from continuing operations	75,021	56,854
Adjustments to reconcile net income to net cash provided by operating activities:
Bad debt expense	1	79
Depreciation and amortization	40,750	38,677
Deferred income taxes	4,881	(2,656)
Equity in earnings of unconsolidated entities	(5,302)	(2,394)
Distribution on investment in AVAIL joint venture	5,155	0
Net gain on sale of property, plant and equipment	(487)	(13)
Amortization of debt financing costs	6,219	6,062
Share-based compensation expense	7,448	4,019
Changes in current assets and current liabilities	(8,493)	21,385
Changes in other long-term assets and long-term liabilities	(5,763)	(3,672)
Net cash provided by operating activities	119,430	118,341
Cash flows from investing activities
Purchase of property, plant and equipment	(59,501)	(42,726)
Other investing activities	761	20
Net cash used in investing activities	(58,740)	(42,706)
Cash flows from financing activities:
Proceeds from issuance of common stock	310,237	1,464
Redemption of Series A Preferred Stock	(308,920)	0
Tax payments related to net share settlement of equity awards	(4,977)	(791)
Proceeds from Revolving Credit Facility	193,000	142,000
Payments on Revolving Credit Facility	(148,000)	(202,000)
Payments of debt financing costs	(715)	(1,203)
Payments on long term debt and finance lease liabilities	(90,432)	(162)
Payments of dividends	(12,943)	(15,688)
Net cash used in financing activities	(62,750)	(76,380)
Effect of exchange rate changes on cash	(137)	33
Net decrease in cash and cash equivalents	(2,197)	(712)
Cash and cash equivalents at beginning of period	4,349	2,820
Cash and cash equivalents at end of period	$ 2,152	$ 2,108